Literature DB >> 26815726

Social Responsibility in Stem Cell Research - Is the News All Bad?

Shelly Benjaminy1, Cody Lo1, Judy Illes2.   

Abstract

Transparent public discourse about translational stem cell research promotes informed hope about scientific progress and the sustainable development of biotechnologies. Using an a priori coding scheme, we surveyed articles from leading news media about stem cell interventions for neurodegenerative diseases (1991-2014) from United States (n = 83), Canada (n = 29), and United Kingdom (n = 65). While, this analysis of translational contexts in the news demonstrates a lingering tendency to celebrate the benefits of research with little context of its caveats even for chronic neurologic diseases, in a departure from many previous studies, the data also reveal conscientious reporting about stem cell tourism and timeframe estimates for the development of relevant therapeutics.

Entities:  

Keywords:  Clinical translation; Neurodegeneration; Science communication; Social responsibility; Stem cells

Mesh：

Year:  2016        PMID： 26815726     DOI： 10.1007/s12015-016-9646-8

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN： 2629-3277            Impact factor:   5.739


  13 in total

Review 1.  fMRI in the public eye.

Authors:  Eric Racine; Ofek Bar-Ilan; Judy Illes
Journal:  Nat Rev Neurosci       Date:  2005-02       Impact factor: 34.870

2.  The quality of media reports on discoveries related to human genetic diseases.

Authors:  Neil A Holtzman; Barbara A Bernhardt; Eliza Mountcastle-Shah; Joann E Rodgers; Ellen Tambor; Gail Geller
Journal:  Community Genet       Date:  2005

Review 3.  Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine.

Authors:  Darren Lau; Ubaka Ogbogu; Benjamin Taylor; Tania Stafinski; Devidas Menon; Timothy Caulfield
Journal:  Cell Stem Cell       Date:  2008-12-04       Impact factor: 24.633

4.  The global landscape of stem cell clinical trials.

Authors:  Matthew D Li; Harold Atkins; Tania Bubela
Journal:  Regen Med       Date:  2013-11-18       Impact factor: 3.806

5.  An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-06       Impact factor: 2.571

6.  Research ethics and stem cells: Is it time to re-think current approaches to oversight?

Authors:  Timothy Caulfield; Kalina Kamenova; Ubaka Ogbogu; Amy Zarzeczny; Jay Baltz; Shelly Benjaminy; Paul A Cassar; Marianne Clark; Rosario Isasi; Bartha Knoppers; Lori Knowles; Gregory Korbutt; James V Lavery; Geoffrey P Lomax; Zubin Master; Michael McDonald; Nina Preto; Maeghan Toews
Journal:  EMBO Rep       Date:  2014-12-04       Impact factor: 8.807

Review 7.  Stem cell hype: media portrayal of therapy translation.

Authors:  Kalina Kamenova; Timothy Caulfield
Journal:  Sci Transl Med       Date:  2015-03-11       Impact factor: 17.956

8.  Clinical development success rates for investigational drugs.

Authors:  Michael Hay; David W Thomas; John L Craighead; Celia Economides; Jesse Rosenthal
Journal:  Nat Biotechnol       Date:  2014-01       Impact factor: 54.908

9.  Contemporary neuroscience in the media.

Authors:  Eric Racine; Sarah Waldman; Jarett Rosenberg; Judy Illes
Journal:  Soc Sci Med       Date:  2010-06-04       Impact factor: 4.634

10.  Ocular gene transfer in the spotlight: implications of newspaper content for clinical communications.

Authors:  Shelly Benjaminy; Tania Bubela
Journal:  BMC Med Ethics       Date:  2014-07-16       Impact factor: 2.652
View more
  8 in total

1.  A Dichotomy of Information-Seeking and Information-Trusting: Stem Cell Interventions and Children with Neurodevelopmental Disorders.

Authors:  Kimberly Sharpe; Nina Di Pietro; Karen J Jacob; Judy Illes
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

2.  Perspectives About Time Frames in Stem Cell Research for Multiple Sclerosis: "Time Is Brain".

Authors:  Shelly Benjaminy; Cody Lo; Andrew Schepmyer; Anthony Traboulsee; Judy Illes
Journal:  Int J MS Care       Date:  2019 Jul-Aug

3.  Clinician views on and ethics priorities for authorizing medical cannabis in the care of children and youth in Canada: a qualitative study.

Authors:  Margot Gunning; Ari D Rotenberg; Lauren E Kelly; Bruce Crooks; Sapna Oberoi; Adam L Rapoport; S Rod Rassekh; Judy Illes
Journal:  CMAJ Open       Date:  2022-03-15

Review 4.  Blood-brain barrier and foetal-onset hydrocephalus, with a view on potential novel treatments beyond managing CSF flow.

Authors:  M Guerra; J L Blázquez; E M Rodríguez
Journal:  Fluids Barriers CNS       Date:  2017-07-13

Review 5.  A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine.

Authors:  Judy Illes; Douglas Sipp; Erika Kleiderman; Shelly Benjaminy; Rosario Isasi; Geoff Lomax; Zubin Master; Jennifer McCormick; Ubaka Ogbogu; Vardit Ravitsky; Julie M Robillard; Fabio Rossi; Brenda Wilson; Amy Zarzeczny
Journal:  NPJ Regen Med       Date:  2017-07-05

Review 6.  Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials.

Authors:  Erika Kleiderman; Audrey Boily; Craig Hasilo; Bartha Maria Knoppers
Journal:  Stem Cell Res Ther       Date:  2018-11-08       Impact factor: 6.832

Review 7.  Reflections on translation: Views of participants in a multisite Canadian CCSVI clinical trial.

Authors:  Shelly Benjaminy; Cody Lo; Judy Illes; Anthony Traboulsee
Journal:  Neurol Clin Pract       Date:  2018-06

8.  Resilience, trust, and civic engagement in the post-CCSVI era.

Authors:  Shelly Benjaminy; Andrew Schepmyer; Judy Illes; Anthony Traboulsee
Journal:  BMC Health Serv Res       Date:  2018-05-16       Impact factor: 2.655
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.